Our findings, using inhibition of
Mab21l2 at specific time points, indicate that
Mab21l2 plays different important roles during separate phases of eye development. An early inhibition of
Mab21l2 in the prospective optic vesicle region, when RPCs proliferate and normally expand the retinal cell population, leads to a clear decrease in proliferation. In addition, the development of the retina is arrested at optic vesicle stages, which consequently results in an anophthalmic phenotype. This resembles the bilateral anophthalmia observed in human individuals with the identified
Mab21l2 R51C mutation.
6,8 In addition, our results are in accordance with previous studies of
Mab21l2-disrupted zebrafish and mouse embryos, which also exhibit MAC phenotypes.
6,12,27 Inhibition of
Mab21l2 by optic cup stages resulted in the formation of microphthalmic coloboma, a phenotype observed in
Mab21l2 R51H and E49L human mutations.
8 Moreover, in human
Mab21l2 mutations, the congenital malformations of the optic disc, associated with significantly impaired visual function, are excavation of the optic disc and optic nerve hypoplasia.
6–8 Both of these features are observed in our chick
Mab21l2-deficient model. Moreover, the
Mab21l2-deficient optic head axons show decreased NF-M expression, whose function is required for axon growth and guidance.
29 Thus, our study provides evidence that in the absence of
Mab21l2 in the GCL, the optic head axons are aggregated and fail to extend to form a normal funnel-shaped optic disc. A previous study has shown that newly postmitotic RGCs express MAP protein, and that the initial broad expression pattern through the retina later becomes confined to the GCL.
20 Our data showing persistent expression of MAP throughout the
Mab21l2-deficient retina suggests that in the absence of
Mab21l2, retinal neuronal precursors cannot differentiate properly into RGCs, which further explains the optic nerve hypoplasia.